Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients

Ozdemir, N.; Aksoy, S.; Sendur, M.; Akinci, M.; Yazici, O.; Budakoglu, B.; Abali, H.; Oksuzoglu, B.; Zengin, N.

Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients

Atıf İçin Kopyala

Ozdemir N., Aksoy S., Sendur M. A. N., Akinci M. B., Yazici O., Budakoglu B., ...Daha Fazla

JOURNAL OF BUON, cilt.18, sa.4, ss.831-837, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 4
Basım Tarihi: 2013
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.831-837
Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the activity and toxicity of the combination of capecitabine and cisplatin (CapCisp) in anthracycline- and taxane-pretreated HER-2 negative metastatic breast carcinoma (MBC) female patients.